Cytokine Signalling Forum
Rheumatology Author Roy Fleischmann: Switching Between UPA and ADA
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:20:16
- Mas informaciones
Informações:
Sinopsis
Professor Roy Fleischmann, from the University of Texas Southwestern Medical Centre in Dallas, discusses data from the SELECT-COMPARE trial, where patients with RA were switched between upadacitinib and adalimumab in cases of insufficient response.
